Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd. (DNPUF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
10. 50
+2.09
+24.8514%
$
4.55B Market Cap
- P/E Ratio
0.11% Div Yield
118 Volume
0 Eps
$ 8.41
Previous Close
Add Transaction
Day Range
10.5 10.5
Year Range
7.24 19.2
Want to track DNPUF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DNPUF closed Friday higher at $10.5, an increase of 24.8514% from Thursday's close, completing a monthly increase of 11.5834% or $1.09. Over the past 12 months, DNPUF stock lost -26.8802%.
DNPUF pays dividends to its shareholders, with the most recent payment made on Jun 28, 2023. The next estimated payment will be in 28 Jun 2023 on Jun 28, 2023 for a total of $0.053.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0.0966%. On average, the company has surpassed earnings expectations by 0.0322%, based on the last three reports.
Sumitomo Pharma Co., Ltd. has completed 2 stock splits, with the recent split occurring on Mar 26, 1992.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on JPX (JPY).

DNPUF Chart

People also search for

Isuzu Motors Ltd. Unsponsored ADR
$ 14.51
0%
Biomerieux SA - Unsponsored ADR
$ 8.82
+2.0184%
Siam Cement Public Company Limited (Unsponsored ADR)
$ 8.56
0%
Pandora A/S
$ 15.27
-0.8442%
Sodexo S.A. Sponsored ADR
$ 13.01
-1.2898%

Sumitomo Pharma Co., Ltd. (DNPUF) FAQ

What is the stock price today?

The current price is $10.50.

On which exchange is it traded?

Sumitomo Pharma Co., Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is DNPUF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.11%.

What is its market cap?

As of today, the market cap is 4.55B.

Has Sumitomo Pharma Co., Ltd. ever had a stock split?

Sumitomo Pharma Co., Ltd. had 2 splits and the recent split was on Mar 26, 1992.

Sumitomo Pharma Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Toru Kimura CEO
OTC PINK Exchange
JP3495000006 ISIN
JP Country
4,980 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Sumitomo Pharma Co., Ltd., originally known as Sumitomo Dainippon Pharma Co., Ltd., underwent a name change in April 2022 and is well established in the pharmaceutical industry. The company, rooted in a rich history dating back to 1897, has expanded its operations beyond its headquarters in Osaka, Japan, to achieve a global footprint. This expansion encompasses key markets in North America, China, and various international locations. As a prominent player in the pharmaceutical sector, Sumitomo Pharma is committed to the discovery, development, and distribution of a wide range of products aimed at improving human and animal health. Its comprehensive portfolio includes pharmaceuticals, food ingredients and additives, veterinary medicines, and more. The company's significant role in the pharmaceutical industry is further evidenced by its strategic partnerships and collaborations with research institutions such as Keio University, RIKEN, Kyoto University, and industry counterparts like Otsuka Pharmaceutical Co., Ltd., and Roivant Sciences Ltd. Operating under the umbrella of Sumitomo Chemical Company, Limited, Sumitomo Pharma adheres to its mission of enhancing healthcare through innovation.

Products and Services

Sumitomo Pharma Co., Ltd. boasts a diverse array of products and services across several categories, underscoring its extensive contribution to the pharmaceutical and healthcare industry.

  • Pharmaceutical Products: The company's pharmaceutical portfolio addresses a wide spectrum of medical conditions, offering therapeutic agents for diseases such as Parkinson's disease, uterine fibroids, depression, type 2 diabetes, and many more. This category also encompasses advanced treatments for conditions like systemic fungal infection, hypertension, and chronic diseases including cancer, respiratory, and cardiovascular diseases.
  • Food Ingredients and Additives: Expanding beyond pharmaceuticals, Sumitomo Pharma provides a range of polysaccharides used as food ingredients and additives. This segment caters to the food industry, offering products like soups, bouillons, and other seasonings, thereby enhancing the nutritional and taste profile of various food products.
  • Chemical Product Materials: The company also engages in the manufacture and distribution of chemical materials for a variety of applications. This includes pharmaceutical excipients, personal care products, coatings, industrial materials, and electronic materials, showcasing Sumitomo Pharma's versatility and competency in chemical technologies.
  • Veterinary Medicines: Sumitomo Pharma's commitment to health extends to the animal kingdom, offering a range of veterinary medicines targeted at companion animals like dogs and cats, as well as livestock including cattle, swine, poultry, horses, and aquacultured fish. These products are designed to improve the health and well-being of animals, contributing to the broader spectrum of healthcare.

Contact Information

Address: 6-8, Doshomachi 2-chome
Phone: 81 6 6203 5321